Evidence map›Paper›PMID 37582706›Full record

ArticleMolecular medicine (Cambridge, Mass.)2023

Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity.

Xiaoxia Xiao, Huiling Hu, Yadi Zhong, Yingjian Chen, Kaijia Tang, Zhisen Pan, Jiawen Huang, Xiaoying Yang, Qi Wang, Yong Gao

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Microglial Feimin Alleviates Cognitive Impairment in High-Fat Diet-Fed Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xiaoxia XiaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Huiling HuDepartment of Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510289, China.
Yadi ZhongScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Yingjian ChenScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Kaijia TangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Zhisen PanFirst Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Jiawen HuangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Xiaoying YangJiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. yxyxiaoliqq@163.com.
Qi WangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. wangqi@gzucm.edu.cn.
Yong GaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. gaoyong@gzucm.edu.cn.ORCID http://orcid.org/0000-0002-7795-3649
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNSun Yat-sen University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroglia play a pivotal role in neuroinflammation, while obesity triggers hypothalamic microglia activation and inflammation. Sirt6 is an important regulator of energy metabolism in many peripheral tissues and hypothalamic anorexic neurons. However, the exact mechanism for microglia Sirt6 in controlling high-fat diet-induced obesity remain unknown.

methodsMicroglia Sirt6 expression levels under various nutritional conditions were measured in the hypothalamus of mice. Also, microglia Sirt6-deficient mice were provided various diets to monitor metabolic changes and hypothalamic inflammatory response. Besides, RNA-seq and Co-IP of microglia with Sirt6 alterations were conducted to further investigate the detailed mechanism by which Sirt6 modulated microglia activity.

resultsWe found that Sirt6 was downregulated in hypothalamic microglia in mice given a high-fat diet (HFD). Additionally, knockout of microglia Sirt6 exacerbated high-fat diet-induced hypothalamic microglial activation and inflammation. As a result, mice were more prone to obesity, exhibiting a decrease in energy expenditure, impaired glucose tolerance, insulin and leptin resistance, and increased food intake. In vitro, Sirt6 overexpression in BV2 cells displayed protective effects against oleic acid and palmitic acid treatment-derived inflammatory response. Mechanically, Sirt6 deacetylated and stabilised NRF2 to increase the expression of anti-oxidative genes and defend against reactive oxygen species overload. Pharmacological inhibition of NRF2 eliminated the beneficial modulating effects of Sirt6 on microglial activity.

conclusionCollectively, our results revealed that microglial Sirt6 was a primary contributor of microglial activation in the central regulation of obesity. Thus, microglial Sirt6 may be an important therapeutic target for obesity.

Indexed as

MicrogliaSirtuinsAnimalsDiet, High-FatHypothalamusInflammationMiceMice, Inbred C57BLNF-E2-Related Factor 2ObesityNF-E2-Related Factor 2Sirt6 protein, mouseSirtuinsHypothalamic inflammationMicroglial activationNRF2ObesitySirt6

Identifiers

PMID37582706
PMCPMC10428617
OpenAlexW4385835769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.